Medical device manufacturers are adjusting their marketing tactics “in an effort to position themselves at the forefront of value-based care,” wrote Ryan Parker, in a post on his company website last month. And this week, Johnson & Johnson Medical Device Companies provided an example for others to follow with a new program which is designed to support the movement from volume- to value-based care and even includes a risk-sharing option.
